Treatment Indications: correction of moderate to deep facial wrinkles and folds (including nasolabial folds, glabellar lines),, volume restoration in mid‑face, nose, and chin areas requiring a medium‑viscosity gel with enhanced structural stability;, contouring applications where resistance to migration and long‑term shape retention are critical
Release form: 1 × 1.0 mL pre‑filled syringe
Compound: cross‑linked hyaluronic acid (non‑animal origin, produced via biofermentation) with particle size 500–600 µm; lidocaine hydrochloride; phosphate‑buffered saline solution
Concentration of GC: 20 mg/mL
Lidocaine: 0.3%
Indications: facial aesthetic correction in mid to deep dermal layers:, filling moderate to deep folds, restoring volume in depressed areas,, enhancing facial contours (cheeks, nose, chin) with a gel optimized for durability (10–14 months) and minimal tissue displacement